Commonwealth Diagnostics International, Inc.

MyGI Gateway will transform hydrogen and methane breath testing with streamlined kit registration, advanced patient engagement, and analytics throughout the diagnostic process.

CDI's industry-leading non-invasive at-home hydrogen and methane breath tests for Small Intestinal Bacterial Overgrowth (SIBO) and Intestinal Methanogen Overgrowth (IMO) as well as fructose, lactose, and sucrose malabsorption are now available for...

CDI recognized for commitment to delivering patient-centric, cost-effective portfolio of diagnostic and technology solutions to the GI community